Skip to content

Resmed Inc

RMD· NYSECore metricsCIK 943819

Surgical & medical instruments & apparatus143 peers

Last sale
Nov 12, 2026 · +0.25%
Market cap
$33.64B
140.66M shares
Filings
1,070
$1.41B
Q1 2027+9.9% FY26 yoy
$418.41M
Q1 2027+8.8% FY26 yoy
$452.98M
Q1 2027+11.9% FY26 yoy
$373.68M
Q1 2027derived−0.7% FY26 yoy
$2.92
Q1 2027+9.7% FY26 yoy
$1.01B
Q1 2027+21.5% FY26 yoy
$33.64B
21.1×
5.9×
5.7×
4.78%
1.06%

Twelve months to Sep 30, 2026 · derived

Price

$239.155.24%$13.22past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.65BFY 2026
$5.65B0FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$5,653,443,000reported
FY 20252025-06-30$5,146,327,000reported
FY 20242024-06-30$4,685,297,000reported
FY 20232023-06-30$4,222,993,000reported
FY 20222022-06-30$3,578,127,000reported
FY 20212021-06-30$3,196,825,000reported
FY 20202020-06-30$2,957,013,000reported
FY 20192019-06-30$2,606,572,000reported
FY 20182018-06-30$2,340,196,000reported
FY 20172017-06-30$2,066,700,000reported
FY 20162016-06-30$1,838,713,000reported
FY 20152015-06-30$1,678,912,000reported

Capital returns

Dividends and buybacks · FY2014 to FY2026
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2026$349.66M$700.04M$1.05B$2.40144.25M sh−1.5%63.6%
FY2025$310.88M$300.03M$610.91M$2.12146.41M sh−0.4%36.8%
FY2024$282.32M$150.01M$432.33M$1.92146.93M sh−0.1%33.2%
FY2023$258.28M$0.00$258.28M$1.76147.07M sh+0.4%45.0%
FY2022$245.34M$0.00$245.34M$1.68146.42M sh+100,410.7%113.4%

Segments

Revenue by Segments, FY2019 to FY2026FY2019Sleep and Respiratory Care · FY2019 · $2.33BSoftware As A Service Before Deferred Revenue Adjustment · FY2019 · $281.14MSoftware as a Service · FY2019 · $275.79MFY2020Sleep and Respiratory Care · FY2020 · $2.60BSoftware As A Service Before Deferred Revenue Adjustment · FY2020 · $356.73MSoftware as a Service · FY2020 · $354.63MFY2021Sleep and Respiratory Care · FY2021 · $2.82BSoftware As A Service Before Deferred Revenue Adjustment · FY2021 · $373.59MSoftware as a Service · FY2021 · $373.59MSoftware as a Service · FY2021 · $373.59MFY2022Sleep and Respiratory Care · FY2022 · $3.18BSleep and Respiratory Care · FY2022 · $3.18BSoftware as a Service · FY2022 · $400.83MSoftware as a Service · FY2022 · $400.83MFY2023Sleep and Breathing Health · FY2023 · $3.73BResidential Care Software · FY2023 · $497.98MSleep and Respiratory Care · FY2023 · $3.73BSleep and Respiratory Care · FY2023 · $3.73BSoftware as a Service · FY2023 · $497.98MFY2024Sleep and Breathing Health · FY2024 · $4.10BResidential Care Software · FY2024 · $584.13MSleep and Respiratory Care · FY2024 · $4.10BSoftware as a Service · FY2024 · $584.13MFY2025Sleep and Breathing Health · FY2025 · $4.50BResidential Care Software · FY2025 · $641.44MFY2026Sleep and Breathing Health · FY2026 · $4.98BResidential Care Software · FY2026 · $675.81M
LineFY2026ShareChange
Sleep and Breathing Health$4.98B88%+10.5%
Residential Care Software$675.81M12%+5.4%
Sleep and Respiratory Care———
Sleep and Respiratory Care———
Software As A Service Before Deferred Revenue Adjustment———
Software as a Service———
Software as a Service———
Total$5.65B

From the 10-K filed Aug 13, 2026RMD

Surgical & medical instruments & apparatus

Resmed Inc is the 8th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Resmed Inc · CIK 943819 · Engraved from SEC EDGAR